Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 2/20 | 0.96 |
| ▸ | FNTA | P49354 | 16/20 | 0.68 |
| ▸ | FNTB | P49356 | 14/20 | 0.68 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylallyl Diphosphate SCHEMBL156447 | 0.98 | BTN3A1 (1.00) | BTN3A1FNTAFNTBPGGT1B | |
| Dimethylallyl Diphosphate SCHEMBL153577 | 0.98 | BTN3A1 (1.00) | BTN3A1FNTAFNTBPGGT1B | |
| Dimethylallyl Diphosphate SCHEMBL28284481 | 0.98 | BTN3A1 (1.00) | BTN3A1FNTAFNTBPGGT1B | |
| Dimethylallyl Diphosphate SCHEMBL3890471 | 0.96 | BTN3A1 (0.96) | BTN3A1FNTAFNTBPGGT1B | |
| Dimethylallyl Diphosphate SCHEMBL28319077 | 0.96 | BTN3A1 (0.96) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL18486682 | 0.94 | BTN3A1 (0.92) | BTN3A1FNTAFNTBPGGT1B | |
| Dimethylallyl Diphosphate SCHEMBL21571346 | 0.94 | BTN3A1 (0.92) | BTN3A1FNTAFNTBPGGT1B | |
| Dimethylallyl Diphosphate SCHEMBL21571329 | 0.91 | BTN3A1 (0.86) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL9963967 | 0.90 | BTN3A1 (0.84) | BTN3A1FNTAFNTBPGGT1B | |
| Dimethylallyl Diphosphate SCHEMBL16930868 | 0.88 | BTN3A1 (0.80) | BTN3A1FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1005651-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-06-07 | — | — | EP | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
| CN-115175758-B | Thermally expandable microspheres, process for production thereof, and use thereof | 松本油脂制药株式会社 | 2023-11-07 | — | — | CN | disclosed |
| CN-115353889-A | Saline-alkali soil conditioner and preparation method thereof | 宁波费尔诺生物科技有限公司 | 2022-11-18 | — | — | CN | disclosed |
| CN-115175758-A | Thermally expandable microspheres, process for producing the same, and use thereof | 松本油脂制药株式会社 | 2022-10-11 | — | — | CN | disclosed |
| US-20190054186-A1 | Magnetic Nanoparticle-Polymer Complexes and uses Thereof | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2019-02-21 | — | — | US | disclosed |
| US-10184137-B2 | Method of producing isoprene monomer | AJINOMOTO CO., INC. (JP) | 2019-01-22 | — | — | US | disclosed |
| WO-2017173205-A1 | MAGNETIC NANOPARTICLE-POLYMER COMPLEXES AND USES THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2017-10-05 | — | — | WO | disclosed |
| EP-3122868-A2 | METHOD OF PRODUCING ISOPRENE MONOMER | Ajinomoto Co., Inc. (JP) | 2017-02-01 | — | — | EP | disclosed |
| US-20150275233-A1 | METHOD OF PRODUCING ISOPRENE MONOMER | AJINOMOTO CO., INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-8415400-B2 | Synthesizing an amphiphilic block polymer micelle having ionically-charged polymeric segments and nonionically-charged polymeric segments; neutralizing under conditions that allow for self-assembly of polymer micelles; crosslinking; removing the moieties of opposite charge; drug delivery; stability | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2013-04-09 | — | — | US | disclosed |
| EP-1109539-A1 | NANOGEL NETWORKS AND BIOLOGICAL AGENT COMPOSITION THEREOF | SUPRATEK PHARMA, INC. (CA) | 2001-06-27 | — | — | EP | disclosed |
| EP-1005324-A4 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIV NEBRASKA (US) | 2001-06-06 | — | — | EP | disclosed |
| EP-1056469-A1 | NOVEL PEPTIDE COPOLYMER COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-12-06 | — | — | EP | disclosed |
| US-6093391-A | PEPTIDE COMPOSITIONS CONTAINING POLYOXYETHYLENE-POLYOXYPROPYLENE BLOCK COPOLYMERS THAT ARE USEFUL IN TREATMENT OF DISEASES AND DISORDERS WITH REDUCED SIDE EFFECTS, EASE IN ADMINISTERING TO DESIRED TARGET SITE, | SUPRATEK PHARMA, INC. (CA) | 2000-07-25 | — | — | US | disclosed |
| EP-1005324-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 2000-06-07 | — | — | EP | disclosed |
| WO-2000013677-A1 | NANOGEL NETWORKS AND BIOLOGICAL AGENT COMPOSITION THEREOF | SUPRATEK PHARMA, INC. (CA) | 2000-03-16 | — | — | WO | disclosed |
| WO-1999043343-A1 | NOVEL PEPTIDE COPOLYMER COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-09-02 | — | — | WO | disclosed |
| WO-1998056348-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998056334-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-12-17 | — | — | WO | disclosed |